BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 9329630)

  • 21. Treatment of high-risk neuroblastoma with anti-GD2 antibodies.
    Castel V; Segura V; CaƱete A
    Clin Transl Oncol; 2010 Dec; 12(12):788-93. PubMed ID: 21156409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.
    Brignole C; Marimpietri D; Pagnan G; Di Paolo D; Zancolli M; Pistoia V; Ponzoni M; Pastorino F
    Cancer Lett; 2005 Oct; 228(1-2):181-6. PubMed ID: 15936140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted radiotherapy and immunotherapy of human neuroblastoma with GD2 specific monoclonal antibodies.
    Cheung NK; Munn D; Kushner BH; Usmani N; Yeh SD
    Int J Rad Appl Instrum B; 1989; 16(2):111-20. PubMed ID: 2497088
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody fragments for controlled delivery of therapeutic agents.
    Verhoeyen ME; van der Logt CP; Beggs TS; Davis PJ
    Biochem Soc Trans; 1995 Nov; 23(4):1067-73. PubMed ID: 8654683
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytotoxic effect of immunoconjugate composed of glucose-oxidase coupled to an anti-ganglioside (GD2) antibody on spheroids.
    Heiss P; Bernatz S; Bruchelt G; Senekowitsch-Schmidtke R
    Anticancer Res; 1997; 17(4B):3177-8. PubMed ID: 9329630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy with GD2 specific monoclonal antibodies.
    Cheung NK; Medof ME; Munn D
    Prog Clin Biol Res; 1988; 271():619-32. PubMed ID: 3043454
    [No Abstract]   [Full Text] [Related]  

  • 27. Disialoganglioside directed immunotherapy of neuroblastoma.
    Modak S; Cheung NK
    Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with interleukin-2 and antitumor monoclonal antibodies.
    Sondel PM; Hank JA
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S121-7. PubMed ID: 9457407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-based immunotherapy in high-risk neuroblastoma.
    Johnson E; Dean SM; Sondel PM
    Expert Rev Mol Med; 2007 Dec; 9(34):1-21. PubMed ID: 18081947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma.
    Lovat PE; Corazzari M; Di Sano F; Piacentini M; Redfern CP
    Cancer Lett; 2005 Oct; 228(1-2):105-10. PubMed ID: 15907365
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.